• Non ci sono risultati.

Antidepressants for Major Depressive Disorder and Dysthymic Disorder in patients with co-morbid Alcohol Use Disorders: state of the art and a meta-analysis of placebo-controlled randomized trials.

N/A
N/A
Protected

Academic year: 2021

Condividi "Antidepressants for Major Depressive Disorder and Dysthymic Disorder in patients with co-morbid Alcohol Use Disorders: state of the art and a meta-analysis of placebo-controlled randomized trials."

Copied!
1
0
0

Testo completo

(1)

UNIVERSITY OF PISA

RESEARCH DOCTORATE IN NEUROBIOLOGY AND CLINIC OF AFFECTIVE DISORDERS

DEPARTMENT OF PSYCHIATRY, NEUROBIOLOGY, PHARMACHOLOGY AND BIOTECNOLOGIES

THESIS:

Antidepressants for Major Depressive Disorder and Dysthymic

Disorder in patients with co-morbid Alcohol Use Disorders:

state of the art and a meta-analysis of placebo-controlled

randomized trials.

CANDIDATE: SUPERVISING PROFESSOR:

DR. NADIA IOVIENO PROF. MAURO MAURI

HEAD OF DEPARTMENT: PROF. ANTONIO LUCACCHINI

Riferimenti

Documenti correlati

Aventi diritto: L’assistito deve avere residenza anagrafica nell’ambito territoriale della Azienda USL n.5 di Pisa, i soggetti non residenti, compresi quelli

If the river basins are covering a territory that is larger than one country (such as in the case of the river Nile, the Danube etc.) an analysis of the entire basin with its

Sebbene in letteratura si sostenga che molto spesso la modalità di trattazione del rilascio delle specie chimiche dal letto di biomassa influenzi solamente la zona a ridosso

(viii) A metallicity-dependent occurrence probability, α MNS , can increase the production of Eu at early times and at low [Fe/H] values ( ≤−1.0), enabling a DTD with

in this section reinforces the finding that 3C 84 has a BEL region that is photo-ionized by the emission from an optically thick accretion flow similar to the low luminosity

The herein reported results have shown that: i) PLGA is a good, biocompatible material to encapsulate iron oxide particles to yield stable NPs, easily suspended

We investigated the response to variation in CERS6 fold change (FC), as this enzyme plays a central role in the de novo production of (primarily C16:0) ceramide,